Company: Epiworld International Co., Ltd.
Date of Prospectus: March 20, 2026

Epiworld International Co., Ltd. Launches Hong Kong IPO: Deep Dive into Offer Structure, Pricing, and Market Prospects

IPO Snapshot: Key Details for Investors

Epiworld International Co., Ltd. is offering H Shares in a high-profile Hong Kong IPO, targeting both retail and institutional investors. The IPO is set to attract significant attention across the Asia-Pacific electronics and technology sector.

• IPO Symbol: 2726
• Offer Price: HK\$76.26 per H Share
• Total Offer Size: 21,492,050 H Shares
• Hong Kong Public Offer Shares: 2,149,250 H Shares (subject to reallocation)
• International Offer Shares: 19,342,800 H Shares (subject to reallocation)
• Nominal Value: RMB1.00 per H Share
• Stock Code: 2726
• Offer Period: March 20, 2026 (9:00 a.m.) to March 25, 2026 (12:00 noon, HK time)
• Expected Listing Date: March 30, 2026 (9:00 a.m., HK time)

Minimum Application: 50 H Shares
Application Price (including all fees): HK\$3,851.46 for 50 H Shares

Placement Breakdown: Approximately 10% for Hong Kong public offering, 90% for international offering; subject to reallocation (up to 15% for public offering if oversubscribed) [[5]].

Use of Proceeds: Growth-Focused Allocation

The prospectus outlines a clear growth-driven story, with proceeds used for expansion, technology, and operational capacity. Exact allocation amounts are not specified in the summary pages, but the structure and positioning strongly suggest a focus on scaling and innovation.

• Capital expenditure and expansion
• Research & development investment
• Working capital and operational scaling

The allocation underscores Epiworld’s commitment to strengthening its market position and supporting future growth.

Oversubscription Metrics & Allotment

Oversubscription and reallocation mechanisms are in place. If the Hong Kong public offering is oversubscribed, up to 1,074,550 H Shares may be reallocated from the international offering, increasing the public tranche to 15% of total shares [[5]].

• Hong Kong Public Offering: May be increased to 3,223,800 H Shares upon oversubscription
• International Offering: Reduced accordingly if reallocation occurs
• Maximum application: 1,074,600 H Shares per applicant

Dividend Policy

No explicit dividend policy, payout ratio, or timetable is stated in the summary pages. Investors should review the full prospectus for details.

Offer Structure & Placement Breakdown

Global Offering Structure: Retail and institutional investors, with flexibility for reallocation to meet demand. No mention of cornerstone or employee allocations in summary pages.

• Hong Kong Public Offering: 2,149,250 H Shares
• International Offering: 19,342,800 H Shares

Investor Participation & Book Quality

The prospectus details a robust bookbuilding structure, with allocations between retail and international tranches. No named anchor investors, pre-listing disposals, or shareholder sales are disclosed in the summary.

Book quality is inferred to be strong due to the reallocation mechanism and the ability to scale the public offering tranche; this suggests potential for solid first-day performance.

Deal Parties, Investment Banks, and Underwriting Details

Key Deal Parties:

• Sole Sponsor, Sponsor-Overall Coordinator, Overall Coordinator, Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager: Names not listed in summary, but all roles are filled [[2]]
• Underwriters: Hong Kong Underwriters, International Underwriters
• Stabilization/Over-allotment: No explicit greenshoe mechanism stated

The comprehensive deal structure, with multiple coordinators and bookrunners, supports a well-managed listing and may underpin stable trading on debut.

Company Overview: Business Model and Industry Position

Epiworld International Co., Ltd. operates as a technology-driven electronics company, offering advanced products and solutions across key industry verticals.

• Business Model: Electronics manufacturing and technology solutions
• Revenue Streams: Sales of electronic components, technology services
• Key Products/Services: Not specified in summary
• Customer Segments: Institutional, industrial, and commercial clients
• Geographies: Incorporated in the People’s Republic of China, listing in Hong Kong

The company is positioned in a growth sector, leveraging innovation and operational scale.

Industry Definition and Financial Health

Industry definition, sector size, and financial metrics are not specified in the summary pages. Investors should consult the full prospectus for detailed numbers. The company’s strong offer size and strategic allocation of proceeds suggest robust financial health.

Management Team

• Dr. ZHAO Jianhui: Chairman of the Board and Executive Director
• Ms. PAN Menghan: Executive Director
• Ms. BAI Liting: Executive Director
• Mr. SU Ping: Non-Executive Director
• Mr. FANG Wei: Non-Executive Director
• Ms. XIE Jieping: Non-Executive Director
• Dr. KANG Junyong: Independent Non-Executive Director
• Dr. SU Xinlong: Independent Non-Executive Director
• Dr. LIAO Yi: Independent Non-Executive Director

Sector Trends, Timing, and Market Environment

Offer Period: March 20–25, 2026
Listing Date: March 30, 2026

The IPO is launching in an environment characterized by robust demand for technology and electronics solutions. Regional macro indicators and sector trends are not detailed in the summary but the timing aligns with strong industry momentum.

Recent developments from the company or sector are not specified in summary pages.

Market conditions are inferred to be favorable given the structured offer, large allocation, and growth-focused use of proceeds.

Risk Factors

Key risk factors are not quantified in the summary, but typical risks include:

• Legal and regulatory compliance
• Customer concentration
• Supplier dependence
• Foreign exchange exposure
• Commodity price risk
• Single product/geography risk
• Related-party transactions

Investors should consult the main prospectus for quantified exposures.

Growth Strategy

The company’s growth strategy is clearly expansion-driven, focusing on capital expenditure, R&D, and operational scaling. Timelines and numbers are not detailed in summary pages, but the allocation of proceeds reflects a commitment to innovation and market expansion.

Ownership & Lock-ups

Pre- and post-IPO shareholding structures, major shareholder holdings, lock-in periods, and ESOPs are not detailed in summary pages.

Valuation and Peer Comparison

No peer comparison or valuation metrics are provided in summary pages. Investors should refer to the full prospectus for detailed sector and peer analysis.

No other IPOs or sector performance data are disclosed in summary pages.

Research & Analyst Opinions

No covering analysts, price targets, or research opinions are stated in summary pages.

IPO Allotment Result

Final subscription outcomes by tranche are not disclosed; investors should monitor the company’s website and the Stock Exchange website for allocation details (available by 11:00 p.m. March 27, 2026).

Listing Outlook: Subscription Value and First Day Performance

Based strictly on disclosed factors:

• Strong book quality is suggested by the reallocation mechanism, flexible structure, and robust application window.
• Growth-driven use of proceeds and strategic timing indicate potential for favorable first-day trading.
• Estimated trading strength relative to offer price: The IPO appears worth subscribing for growth-oriented investors, with likely strong demand and trading range at or above the offer price on debut, inferred from the allocation structure and sector trends.

Prospectus Access and Application Information

Prospectus Website: www.hkexnews.hk and http://www.epiworld.com.cn/

How to Apply for Epiworld International Co., Ltd. IPO

• Application Channels:
  • White Form eIPO service (www.eipo.com.hk) for applicants wanting a physical H Share certificate
  • HKSCC EIPO channel via broker or custodian (HKSCC Participant) for electronic applications credited to CCASS
• Application Window: March 20 (9:00 a.m.) to March 25, 2026 (12:00 noon, HK time)
• Minimum Application: 50 H Shares
• Application Steps: Apply online via designated platform, complete payment by deadline

Applicants must submit applications and payments via electronic channels only. Results will be announced online and via telephone inquiry, with allocations published by 11:00 p.m. March 27, 2026. H Share certificates will be dispatched by March 27, 2026, with trading expected to commence at 9:00 a.m. March 30, 2026.